ARCHIVES

St. John’s Wort Not Indicated For Patients On Irinotecan

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Other DCE Contract Recompetitions OKed

November 15, 1985

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s

February 28, 1992

Procedures For Ending IGs Announced

July 10, 1992